Introduction. GERD warrants increased physician appreciation and improved treatment

Area of Science:

• Gastroenterology
• Internal Medicine

Background:

• Gastroesophageal reflux disease (GERD) was historically viewed as a minor ailment with limited complications.
• Nocturnal heartburn, a key symptom of GERD, has been significantly underestimated by both the public and primary care physicians.

Purpose of the Study:

• To highlight the substantial adverse effects of nocturnal heartburn on patients' daily lives and overall quality of life.
• To underscore the potential progression of GERD complications, including Barrett's esophagus and malignancy, due to prolonged esophageal acid exposure.

Main Methods:

• Review of current medical understanding and expert opinions on GERD and nocturnal heartburn.
• Discussion of the pathophysiological link between acid reflux, esophageal damage, and long-term complications.
• Analysis of the role of proton pump inhibitors (PPIs) in managing GERD, emphasizing administration timing and agent selection.

Main Results:

• Nocturnal heartburn has a major negative impact on patient well-being and daily functioning.
• Prolonged acid exposure in the esophagus can lead to Barrett's esophagus, which may progress to dysplasia and cancer.
• Effective management requires more aggressive acid suppression strategies.

Conclusions:

• There is a critical need for more potent acid suppressants to manage GERD effectively.
• Optimal efficacy of proton pump inhibitor (PPI) therapy depends on understanding proton pump kinetics and area under the curve (AUC).
• Administering PPIs before the first meal and selecting agents that control nocturnal symptoms are crucial for successful GERD treatment.